Oral cancer is the eleventh most common cancer globally, with well-established major risk factors of tobacco, areca nut, alcohol, and high-risk human papillomavirus (HR-HPV) types 16 and 18. HR-HPV16/18 are the etiologic agents of cervical cancers and a proportion of oropharyngeal cancers. HPV-associated oropharyngeal and oral cancers show better prognosis and response to therapy. However, the picture of HR-HPV16/18 and the clinical implications of oral cancers are not clear with the majority of reports combining oral cancer data with head and neck cancers. The current review compiles the global prevalence of HR-HPV16/18 in oral cancers, highlighting the unique clinical and molecular pathologic features, prognosis and therapeutic strategies in the prevention and management of HPV-positive oral cancers. The potential for the use of de-intensified therapy and prophylactic prevention in HPV-positive oral cancer patients is highlighted.

Keywords:
Oral cancer, Human papillomavirus, Prevalence, Prognosis, Therapy, Vaccine
1.
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-2917.
2.
Argiris A, Karamouzis MV, Raben D, Ferris RL: Head and neck cancer. Lancet 2008;371:1695-1709.
3.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-E386.
4.
World Health Organization: International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10). 2015. http://apps.who.int/classifications/icd10/browse/2015/en#/C00-C14 (accessed July 26, 2017).
5.
Chi AC, Day TA, Neville BW: Oral cavity and oropharyngeal squamous cell carcinoma - an update. CA Cancer J Clin 2015;65:401-421.
6.
Lee KW, Kuo WR, Tsai SM, Wu DC, Wang WM, Fang FM, Chiang FY, Ho KY, Wang LF, Tai CF, Kao EL: Different impact from betel quid, alcohol and cigarette: risk factors for pharyngeal and laryngeal cancer. Int J Cancer 2005;117:831-836.
7.
Marur S, D'Souza G, Westra WH, Forastiere AA: HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010;11:781-789.
8.
Syrjänen K, Syrjänen S, Lamberg M, Pyrhönen S, Nuutinen J: Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg 1983;12:418-424.
9.
Miller CS, Johnstone BM: Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:622-635.
10.
Smith EM, Ritchie JM, Summersgill KF, Klussmann JP, Lee JH, Wang D, Haugen TH, Turek LP: Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 2004;108:766-772.
11.
O'Rorke MA, Ellison MV, Murray LJ, Moran M, James J, Anderson LA: Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. Oral Oncol 2012;48:1191-1201.
12.
Deschler DG, Richmon JD, Khariwala SS, Ferris RL, Wang MB: The “new” head and neck cancer patient - young, nonsmoker, nondrinker, and HPV positive: evaluation. J Otolaryngol Head Neck Surg 2014;151:375-380.
13.
Bzhalava D, Eklund C, Dillner J: International standardization and classification of human papillomavirus types. Virology 2015;476:341-344.
14.
Prabhu SR, Wilson DF: Human papillomavirus and oral disease - emerging evidence: a review. Aust Dent J 2013;58:2-10.
15.
De Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H: Classification of papillomaviruses. Virology 2004;324:17-27.
16.
Kreimer AR, Clifford GM, Boyle P, Franceschi S: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005;14:467-475.
17.
Syrjänen S, Lodi G, von Bültzingslöwen I, Aliko A, Arduino P, Campisi G, Challacombe S, Ficarra G, Flaitz C, Zhou HM, Maeda H: Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Dis 2011;17:58-72.
18.
Ndiaye C, Mena M, Alemany L, Arbyn M, Castellsagué X, Laporte L, Bosch FX, de Sanjosé S, Trottier H: HPV DNA, E6/E7 mRNA, and p16 INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol 2014;15:1319-1331.
19.
Mork J, Lie AK, Glattre E, Clark S, Hallmans G, Jellum E, Koskela P, Møller B, Pukkala E, Schiller JT, Wang Z: Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001;344:1125-1131.
20.
Giuliano AR, Lee JH, Fulp W, Villa LL, Lazcano E, Papenfuss MR, Abrahamsen M, Salmeron J, Anic GM, Rollison DE, Smith D: Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet 2011;377:932-940.
21.
Miranda PM, Silva NN, Pitol BC, Silva ID, Lima-Filho JL, Carvalho RF, Stocco RD, Beçak W, Lima AA: Persistence or clearance of human papillomavirus infections in women in Ouro Preto, Brazil. Biomed Res Int 2013;2013:578276.
22.
Benson E, Li R, Eisele D, Fakhry C: The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas. Oral Oncol 2014;50:565-574.
23.
Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, Graubard BI, Chaturvedi AK: Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012;307:693-703.
24.
Miller CS, White DK: Human papillomavirus expression in oral mucosa, premalignant conditions, and squamous cell carcinoma: a retrospective review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:57-68.
25.
Elango KJ, Suresh A, Erode EM, Subhadradevi L, Ravindran HK, Iyer SK, Iyer SK, Kuriakose MA: Role of human papilloma virus in oral tongue squamous cell carcinoma. Asian Pac J Cancer Prev 2011;12:889-896.
26.
Kumar R, Rai AK, Das D, Das R, Kumar RS, Sarma A, Sharma S, Kataki AC, Ramteke A: Alcohol and tobacco increases risk of high risk HPV infection in head and neck cancer patients: study from north-east region of India. PloS One 2015;10:e0140700.
27.
Maruyama H, Yasui T, Ishikawa-Fujiwara T, Morii E, Yamamoto Y, Yoshii T, Takenaka Y, Nakahara S, Todo T, Hongyo T, Inohara H: Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population. Cancer Sci 2014;105:409-417.
28.
Termine N, Panzarella V, Falaschini S, Russo A, Matranga D, Lo Muzio L, Campisi G: HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Ann Oncol 2008;19:1681-1690.
29.
Klingelhutz AJ, Foster SA, McDougall JK: Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 1996;380:79-82.
30.
Narisawa-Saito M, Kiyono T: Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins. Cancer Sci 2007;98:1505-1511.
31.
Yoshida S, Kajitani N, Satsuka A, Nakamura H, Sakai H: Ras modifies proliferation and invasiveness of cells expressing human papillomavirus oncoproteins. J Virol 2008;82:8820-8827.
32.
Spitkovsky D, Hehner SP, Hofmann TG, Möller A, Schmitz ML: The human papillomavirus oncoprotein E7 attenuates NF-κB activation by targeting the IκB kinase complex. J Biol Chem 2002;277:25576-25582.
33.
Verma G, Vishnoi K, Tyagi A, Jadli M, Singh T, Goel A, Sharma A, Agarwal K, Prasad SC, Pandey D, Sharma S: Characterization of key transcription factors as molecular signatures of HPV-positive and HPV-negative oral cancers. Cancer Med 2017;6:591-604.
34.
Muzio LL, Staibano S, Pannone G, Mignogna MD, Mariggiò A, Salvatore G, Chieffi P, Tramontano D, De Rosa G, Altieri DC: Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp Mol Pathol 2001;70:249-254.
35.
Chaudhary AK, Pandya S, Mehrotra R, Bharti AC, Singh M, Singh M: Comparative study between the Hybrid Capture II test and PCR based assay for the detection of human papillomavirus DNA in oral submucous fibrosis and oral squamous cell carcinoma. Virol J 2010;7:253.
36.
Burd EM: Human papillomavirus laboratory testing: the changing paradigm. Clin Microbiol Rev 2016;29:291-319.
37.
Harris SL, Thorne LB, Seaman WT, Neil Hayes D, Couch ME, Kimple RJ: Association of p16INK4a overexpression with improved outcomes in young patients with squamous cell cancers of the oral tongue. Head Neck 2011;33:1622-1627.
38.
Lingen MW, Xiao W, Schmitt A, Jiang B, Pickard R, Kreinbrink P, Perez-Ordonez B, Jordan RC, Gillison ML: Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol 2013;49:1-8.
39.
Anantharaman D, Abedi-Ardekani B, Beachler DC, Gheit T, Olshan AF, Wisniewski K, Wunsch-Filho V, Toporcov TN, Tajara EH, Levi JE, Moyses RA: Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer. Int J Cancer 2017;140:1968-1975.
40.
Shigeishi H, Sugiyama M: Risk factors for oral human papillomavirus infection in healthy individuals: a systematic review and meta-analysis. J Clin Med Res 2016;8:721.
41.
Kreimer AR, Bhatia RK, Messeguer AL, González P, Herrero R, Giuliano AR: Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis 2010;37:386-391.
42.
Scheifele C, Reichart PA: Is there a natural limit of the transformation rate of oral leukoplakia? Oral Oncol 2003;39:470-475.
43.
Chocolatewala NM, Chaturvedi P: Role of human papilloma virus in the oral carcinogenesis: an Indian perspective. J Cancer Res Ther 2009;5:71.
44.
Barwad A, Sood S, Gupta N, Rajwanshi A, Panda N, Srinivasan R: Human papilloma virus associated head and neck cancer: a PCR based study. Diagn Cytopathol 2012;40:893-897.
45.
Tota JE, Anderson WF, Coffey C, Califano J, Cozen W, Ferris RL, John MS, Cohen EE, Chaturvedi AK: Rising incidence of oral tongue cancer among white men and women in the United States, 1973-2012. Oral Oncol 2017;67:146-152.
46.
Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-720.
47.
Lee SY, Cho NH, Choi EC, Baek SJ, Kim WS, Shin DH, Kim SH: Relevance of human papilloma virus (HPV) infection to carcinogenesis of oral tongue cancer. Int J Oral Maxillofac Surg 2010;39:678-683.
48.
Ritchie JM, Smith EM, Summersgill KF, Hoffman HT, Wang D, Klussmann JP, Turek LP, Haugen TH: Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 2003;104:336-344.
49.
Lee LA, Huang CG, Liao CT, Lee LY, Hsueh C, Chen TC, Lin CY, Fan KH, Wang HM, Huang SF, Chen IH: Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival. PloS One 2012;7:e40767.
50.
Rabik CA, Dolan ME: Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev 2007;33:9-23.
51.
Kimple RJ, Smith MA, Blitzer GC, Torres AD, Martin JA, Yang RZ, Peet CR, Lorenz LD, Nickel KP, Klingelhutz AJ, Lambert PF: Enhanced radiation sensitivity in HPV-positive head and neck cancer. Cancer Res 2013;73:4791-4800.
52.
Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H: Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24-35.
53.
Mirghani H, Amen F, Blanchard P, Moreau F, Guigay J, Hartl DM, Lacau St Guily J: Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives. Int J Cancer 2015;136:1494-1503.
54.
Herrero R, Quint W, Hildesheim A, Gonzalez P, Struijk L, Katki HA, Porras C, Schiffman M, Rodriguez AC, Solomon D, Jimenez S: Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PloS One 2013;8:e68329.
55.
Arnheim-Dahlström L, Pasternak B, Svanström H, Sparén P, Hviid A: Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study. BMJ 2013;347:f5906.
56.
Gee J, Naleway A, Shui I, Baggs J, Yin R, Li R, et al: Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink. Vaccine 2011;29:8279-8284.
57.
Mitra S, Banerjee S, Misra C, Singh RK, Roy A, Sengupta A, Panda CK, Roychoudhury S: Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population. J Clin Pathol 2007;60:1040-1047.
58.
Pal D, Banerjee S, Indra D, Mandal S, Dum A, Bhowmik A, Panda CK, Das S: Influence of regular black tea consumption on tobacco associated DNA damage and HPV prevalence in human oral mucosa. Asian Pac J Cancer Prev 2007;8:263.
59.
Ghosh S, Ghosh A, Maiti GP, Alam N, Roy A, Roy B, Roychoudhury S, Panda CK: Alterations of 3p21.31 tumor suppressor genes in head and neck squamous cell carcinoma: correlation with progression and prognosis. Int J Cancer 2008;123:2594-2604.
60.
Gheit T, Vaccarella S, Schmitt M, Pawlita M, Franceschi S, Sankaranarayanan R, Sylla BS, Tommasino M, Gangane N: Prevalence of human papillomavirus types in cervical and oral cancers in central India. Vaccine 2009;27:636-639.
61.
Majumder M, Indra D, Roy PD, Datta S, Ray JG, Panda CK, Roy B: Variant haplotypes at XRCC1 and risk of oral leukoplakia in HPV non-infected samples. J Oral Pathol Med 2009;38:174-180.
62.
Jalouli J, Ibrahim SO, Mehrotra R, Jalouli MM, Sapkota D, Larsson PA, Hirsch JM: Prevalence of viral (HPV, EBV, HSV) infections in oral submucous fibrosis and oral cancer from India. Acta Otolaryngol 2010;130:1306-1311.
63.
Kulkarni SS, Kulkarni SS, Vastrad PP, Kulkarni BB, Markande AR, Kadakol GS, Hiremath SV, Kaliwal S, Patil BR, Gai PB: Prevalence and distribution of high risk human papillomavirus (HPV) Types 16 and 18 in Carcinoma of cervix, saliva of patients with oral squamous cell carcinoma and in the general population in Karnataka, India. Asian Pac J Cancer Prev 2011;12:645-648.
64.
Mondal R, Ghosh SK, Choudhury JH, Seram A, Sinha K, Hussain M, Laskar RS, Rabha B, Dey P, Ganguli S, Nathchoudhury M, et al: Mitochondrial DNA copy number and risk of oral cancer: a report from Northeast India. PLoS One 2013;8:e57771.
65.
Ramshankar V, Soundara VT, Shyamsundar V, Ramani P, Krishnamurthy A: Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression. Asian Pac J Cancer Prev 2014;15:8351-8359.
66.
Parshad S, Nandi S, Marwah N, Mehta P, Tripathi M: Human papillomavirus 16 and 18 in squamous cell carcinoma of oral cavity and sexual practices: a pilot study at a Tertiary Care Hospital of North India. Natl J Maxillofac Surg 2015;6:185.
67.
Gheit T, Anantharaman D, Holzinger D, Alemany L, Tous S, Lucas E, Prabhu PR, Pawlita M, Ridder R, Rehm S, Bogers J: Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India. Int J Cancer 2017;141:143-151.
68.
Castillo A, Koriyama C, Higashi M, Anwar M, Bukhari MH, Carrascal E, Mancilla L, Okumura H, Matsumoto M, Sugihara K, Natsugoe S: Human papillomavirus in upper digestive tract tumors from three countries. World J Gastroenterol 2011;17:5295.
69.
Seraj JM, Yazdani N, Ashtiani ZO, Seraj SM, Hasheminasab SM, Memar B, Mirashrafi F, Borghei H, Yazdani J, Mostaan LV: TP53 gene expression in HPV-positive oral tongue SCC and its correlation with nodal metastasis. Pathol Res Pract 2011;207:758-761.
70.
Saghravanian N, Ghazi N, Meshkat Z, Mohtasham N: Human papillomavirus in oral leukoplakia, verrucous carcinoma, squamous cell carcinoma, and normal mucous membrane. Oman Med J 2015;30:455.
71.
Mathew A, Mody R, Patait M, Razooki A, Varghese N, Saraf K: Prevalence and relationship of human papilloma virus type 16 and type 18 with oral squamous cell carcinoma and oral leukoplakia in fresh scrappings: a PCR study. Indian J Med Sci 2011;65:212.
72.
Zhao D, Xu QG, Chen XM, Fan MW: Human papillomavirus as an independent predictor in oral squamous cell cancer. Int J Oral Sci 2009;1:119-125.
73.
Gan LL, Zhang H, Guo JH, Fan MW: Prevalence of human papillomavirus infection in oral squamous cell carcinoma: a case-control study in Wuhan, China. Asian Pac J Cancer Prev 2014;15:5861-5865.
74.
Chen F, Yan L, Liu F, Huang J, Liu F, Wu J, Qiu Y, Zheng X, Cai L, Lin L, He B: Oral human papillomavirus infection, sexual behaviors and risk of oral squamous cell carcinoma in southeast of China: a case-control study. J Clin Virol 2016;85:7-12.
75.
Lee LA, Huang CG, Tsao KC, Liao CT, Kang CJ, Chang KP, Huang SF, Chen IH, Fang TJ, Li HY, Yang SL: Human papillomavirus infections are common and predict mortality in a retrospective cohort study of Taiwanese patients with oral cavity cancer. Medicine (Baltimore) 2015;94:e2069.
76.
Sugiyama M, Bhawal UK, Kawamura M, Ishioka Y, Shigeishi H, Higashikawa K, Kamata N: Human papillomavirus-16 in oral squamous cell carcinoma: clinical correlates and 5-year survival. Br J Oral Maxillofac Surg 2007;45:116-122.
77.
Saini R, Tang TH, Zain RB, Cheong SC, Musa KI, Saini D, Ismail AR, Abraham MT, Mustafa WM, Santhanam J: Significant association of high-risk human papillomavirus (HPV) but not of p53 polymorphisms with oral squamous cell carcinomas in Malaysia. J Cancer Res Clin Oncol 2011;137:311-320.
78.
dos Santos Ribeiro CE, da Silva ID, Cerri A, Weckx LL: Prevalence of human papillomavirus in squamous cell carcinoma of the tongue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;104:497-500.
79.
Kaminagakura E, Villa LL, Andreoli MA, Sobrinho JS, Vartanian JG, Soares FA, Nishimoto IN, Rocha R, Kowalski LP: High-risk human papillomavirus in oral squamous cell carcinoma of young patients. Int J Cancer 2012;130:1726-1732.
80.
Hauck F, Oliveira-Silva M, Dreyer JH, Perrusi VJ, Arcuri RA, Hassan R, Bonvicino CR, Barros MH, Niedobitek G: Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany. Virchows Arch 2015;466:685-693.
81.
Betiol JC, Sichero L, de Olival Costa HO, de Matos LL, Andreoli MA, Ferreira S, Faraj SF, de Mello ES, Sobrinho JS, Brandão LG, Cernea CR, Kulcsar MA, Pinto FR, Gonçalves AJ, Menezes MB, Silva L, Rossi LM, Nunes RL, Termini L, Villa LL: Prevalence of human papillomavirus types and variants and p16 INK4a expression in head and neck squamous cells carcinomas in São Paulo, Brazil. Infect Agent Cancer 2016;11:20.
82.
Petito G, Carneiro MA, Santos SH, Silva AM, Alencar RD, Gontijo AP, Saddi VA: Human papillomavirus in oral cavity and oropharynx carcinomas in the central region of Brazil. Braz J Otorhinolaryngol 2017;83:38-44.
83.
Anaya-Saavedra G, Ramírez-Amador V, Irigoyen-Camacho ME, García-Cuellar CM, Guido-Jiménez M, Méndez-Martínez R, García-Carrancá A: High association of human papillomavirus infection with oral cancer: a case-control study. Arch Med Res 2008;39:189-197.
84.
González-Ramírez I, Irigoyen-Camacho ME, Ramírez-Amador V, Lizano-Soberón M, Carrillo-García A, García-Carrancá A, Sánchez-Pérez Y, Méndez-Martínez R, Granados-García M, Ruíz-Godoy LM, García-Cuellar CM: Association between age and high-risk human papilloma virus in Mexican oral cancer patients. Oral Dis 2013;19:796-804.
85.
Quintero K, Giraldo GA, Uribe ML, Baena A, Lopez C, Alvarez E, Sanchez GI: Human papillomavirus types in cases of squamous cell carcinoma of head and neck in Colombia. Braz J Otorhinolaryngol 2013;79:375-381.
86.
Chen KM, Stephen JK, Ghanem T, Stachler R, Gardner G, Jones L, Schweitzer VP, Hall F, Divine G, Worsham MJ: Human papilloma virus prevalence in a multiethnic screening population. Otolaryngol Head Neck Surg 2013;148:436-442.
87.
Laprise C, Madathil SA, Schlecht NF, Castonguay G, Soulières D, Nguyen-Tan PF, Allison P, Coutlée F, Hier M, Rousseau MC, Franco EL: Human papillomavirus genotypes and risk of head and neck cancers: results from the HeNCe Life case-control study. Oral Oncol 2017;69:56-61.
88.
St Guily JL, Jacquard AC, Prétet JL, Haesebaert J, Beby-Defaux A, Clavel C, Agius G, Birembaut P, Okaïs C, Léocmach Y, Soubeyrand B: Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France: the EDiTH VI study. J Clin Virol 2011;51:100-104.
89.
Duray A, Descamps G, Decaestecker C, Remmelink M, Sirtaine N, Lechien J, Ernoux-Neufcoeur P, Bletard N, Somja J, Depuydt CE, Delvenne P: Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma. Laryngoscope 2012;122:1558-1565.
90.
Krüger M, Pabst AM, Walter C, Sagheb K, Günther C, Blatt S, Weise K, Al-Nawas B, Ziebart T: The prevalence of human papilloma virus (HPV) infections in oral squamous cell carcinomas: a retrospective analysis of 88 patients and literature overview. J Craniomaxillofac Surg 2014;42:1506-1514.
91.
Polz-Gruszka D, Morshed K, Stec A, Polz-Dacewicz M: Prevalence of Human papillomavirus (HPV) and Epstein-Barr virus (EBV) in oral and oropharyngeal squamous cell carcinoma in south-eastern Poland. Infect Agent Cancer 2015;10:37.
92.
Szarka K, Tar I, Fehér E, Gáll T, Kis A, Tóth ED, Boda R, Marton I, Gergely L: Progressive increase of human papillomavirus carriage rates in potentially malignant and malignant oral disorders with increasing malignant potential. Mol Oral Microbiol 2009;24:314-318.
93.
Dediol E, Sabol I, Virag M, Grce M, Muller D, Manojlović S: HPV prevalence and p16INKa overexpression in non-smoking non-drinking oral cavity cancer patients. Oral Dis 2016;22:517-522.
94.
Kouvousi M, Xesfyngi D, Tsimplaki E, Argyri E, Ioannidou G, Ploxorou M, Lazaris AC, Patsouris E, Panotopoulou E: Prevalence of human papillomavirus in 45 Greek patients with oral cancer. J Oncol 2013;2013.
95.
Tsimplaki E, Argyri E, Xesfyngi D, Daskalopoulou D, Stravopodis DJ, Panotopoulou E: Prevalence and expression of human papillomavirus in 53 patients with oral tongue squamous cell carcinoma. Anticancer Res 2014;34:1021-1025.
96.
Rodolico V, Arancio W, Amato MC, Aragona F, Cappello F, Di Fede O, Pannone G, Campisi G: Hypoxia inducible factor-1 alpha expression is increased in infected positive HPV16 DNA oral squamous cell carcinoma and positively associated with HPV16 E7 oncoprotein. Infect Agent Cancer 2011;6:18.
97.
Antonsson A, Neale RE, Boros S, Lampe G, Coman WB, Pryor DI, Porceddu SV, Whiteman DC: Human papillomavirus status and p16 INK4A expression in patients with mucosal squamous cell carcinoma of the head and neck in Queensland, Australia. Cancer Epidemiol 2015;39:174-181.
98.
Emmett S, Jenkins G, Boros S, Whiteman DC, Panizza B, Antonsson A: Low prevalence of human papillomavirus in oral cavity squamous cell carcinoma in Queensland, Australia. ANZ J Surg 2017;87:714-719.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.